Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Kidney Diseases
>>
AbbVie
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Xinlay
(atrasentan) / Novartis
ABT-751
/ AbbVie, Eisai
Humira
(adalimumab) / AbbVie
derenofylline
(SLV320) / AbbVie
modimelanotide
(ABT-719) / AbbVie
Proellex
(telapristone) / AbbVie
Xcytrin
(motexafin gadolinum) / AbbVie
daglutril
(KC 12615) / Abbott, AbbVie
linifanib
(ABT-869) / AbbVie
thrombospondin-1 mimetic
(ABT-510) / AbbVie
volociximab
(M200) / AbbVie, Biogen
